Related Experiment Video
Updated: Jun 3, 2026
09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
Cancer Medication Consumptions in Vietnam Between 2019 and 2023: An Analysis from the National Database
Mai Thi Tuyet Kieu1, Duc Quang Tran2, Anh Thi Phuong Le1
1Department of Pharmaceutical Economics, Faculty of Pharmaceutical Management and Economics, Hanoi University of Pharmacy, Hanoi, Vietnam.
Clinicoeconomics and Outcomes Research : CEOR
|June 2, 2026
Summary
Cancer medication consumption in Vietnam saw significant fluctuations between 2019-2023, with targeted therapies dominating expenditures. Policy changes are needed to optimize medication impact and reduce the cancer burden.
Area of Science:
- Health Economics
- Oncology
- Pharmaceutical Policy
Background:
- Cancer medication consumption is a critical component of healthcare expenditure in Vietnam.
- Understanding consumption patterns is vital for effective resource allocation and policy development.
Purpose of the Study:
- To analyze cancer medication consumption trends in Vietnam from 2019 to 2023.
- To investigate the relationship between consumption, price, and bidding mechanisms.
Main Methods:
- Cross-sectional study utilizing publicly available data from the Drug Administration of Vietnam (DAV).
- Data extraction and categorization by technical groups, chemical classes, procurement levels, origin, and administration routes.
- Descriptive and statistical analyses to explore consumption, price, and bidding dynamics.
Main Results:
- Total cancer medication consumption estimated at $1.4 billion between 2019-2023, with a peak in 2023 ($359.5 million).
- Targeted therapies (44-48%) consistently led consumption, followed by chemotherapies (34-39%) and immunotherapies (8-16%).
- Originator products and high-quality generics accounted for 73-85% of expenditures; mean price per milligram decreased over time, with centralized bidding proving more efficient.
Conclusions:
- Cancer medication consumption in Vietnam exhibited substantial fluctuations influenced by procurement patterns and the pandemic.
- Targeted policies are essential to optimize the economic impact of cancer medications.
- Broader strategies are necessary to alleviate the overall cancer burden in Vietnam.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...